Senti Biosciences Holdings, Inc.
SNTI
$0.97
-$0.01-0.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 9.40% | 5.30% | -1.13% | 2.92% | 6.87% |
| Gross Profit | -9.33% | -5.30% | 0.19% | -6.95% | -16.12% |
| SG&A Expenses | 12.66% | -9.98% | -25.16% | -48.89% | -51.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.13% | -0.96% | -11.26% | -22.41% | -23.54% |
| Operating Income | -10.08% | 0.96% | 10.77% | 20.87% | 20.50% |
| Income Before Tax | -16.38% | 32.86% | 25.82% | 32.91% | 36.71% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.38% | 32.86% | 25.82% | 32.91% | 36.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.38% | 32.89% | -2.40% | 14.98% | 25.71% |
| EBIT | -10.08% | 0.96% | 10.77% | 20.87% | 20.50% |
| EBITDA | -11.32% | 0.64% | 10.58% | 21.79% | 22.16% |
| EPS Basic | 73.56% | 78.60% | 29.21% | 24.83% | 24.59% |
| Normalized Basic EPS | 60.95% | 76.21% | 61.74% | 48.84% | 41.30% |
| EPS Diluted | 73.56% | 78.60% | 29.21% | 24.83% | 24.59% |
| Normalized Diluted EPS | 60.95% | 76.21% | 61.74% | 48.84% | 41.30% |
| Average Basic Shares Outstanding | 388.02% | 268.33% | 151.07% | 33.00% | 3.57% |
| Average Diluted Shares Outstanding | 388.02% | 268.33% | 151.07% | 33.00% | 3.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |